logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

ATNM
Actinium Pharmaceuticals, Inc.
0.98
400 x undefined
300 x undefined
bid
ask
-
0.00
0.02%
350 @ 04:00 PM
1.00 +0.02 (1.91%)
Ytd-27.96%
1y-27.42%
0.97
day range
0.99
0.94
52 week range
1.89
Open0.97Prev Close0.98Low0.97High0.99Mkt Cap30.74M
Vol90.78KAvg Vol180.83KEPS-0.76P/EN/AForward P/E-1.77
Beta0.15Short Ratio5.72Inst. Own30.11%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0850-d Avg1.15200-d Avg1.291yr Est5.00

ATNM News

benzinga.com
Actinium's ATNM-400 Reports Preclinical Activity And Combination Synergy Across KRAS- And EGFR-Mutan

New KRAS-mutant data show ATNM-400 outperformed standard-of-care inhibitors sotorasib and adagrasib

benzinga.com
Actinium Pharma Presents New Data On ATNM-400 In Prostate Cancer At SNMMI 2026 Annual Meeting

New data demonstrated ATNM-400 remains potently active in prostate cancer cells and tumors resistant